Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
The role of icosapent ethyl in cardiovascular risk...
Journal article

The role of icosapent ethyl in cardiovascular risk reduction

Abstract

PURPOSE OF REVIEW: Elevated levels of triglycerides, independent of low-density lipoprotein cholesterol (LDL-C) levels and statin therapy, are associated with heightened cardiovascular risk. RECENT FINDINGS: Mixed omega-3 fatty acid formulations, which contain varying amounts of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), lower triglycerides levels but trial results with omega-3 fatty acids combinations have generally been …

Authors

Goldenberg RM; Cheng AYY; Gilbert JD; Lonn EM; Pedersen SD; Verma S

Journal

Current Opinion in Cardiology, Vol. 36, No. 5, pp. 661–671

Publisher

Wolters Kluwer

Publication Date

September 2021

DOI

10.1097/hco.0000000000000873

ISSN

0268-4705